In Vitro Fertilization Market Size, Share, Growth, Trends 2025 to 2034

In Vitro Fertilization Market Size and Growth 2025 to 2034

The global in vitro fertilization market size was valued at USD 25.06 billion in 2024 and is expected to be worth around USD 43.76 billion by 2034, growing at a compound annual growth rate (CAGR) of 10.6% from 2025 to 2034.

In the last few years, there have been many developments and trends in fertility treatment that have improved the overall experience and success rate for people who want to start a family. To help individuals and couples conceive, in vitro fertilization (IVF) is a cutting-edge assisted reproductive technology. In this process, a woman's ovaries are stimulated to produce a large number of eggs, which are then surgically removed and fertilized in a lab with sperm. After a few days of culture, the resultant embryos are then placed in the woman's uterus in the hopes of a fruitful pregnancy. IVF is widely used to treat fertility problems in males and females, and genetic disorders.

Significant advancements and modifications have been made in recent years in IVF, which has further enhanced patient outcomes and at the same time has increased the availability of various treatment options. Given the recent high success rate, the integration of new technologies into IVF and other reproductive procedures is being carried on by experts. To overcome the issues related to infertility, over the years, millions of people have used IVF in which an embryo is inserted into the uterus after the sperm and egg are successfully fertilized in a lab.

Report Highlight

• The Asia-Pacific region has lead the market with revenue share of 37.90% in 2024.
• By instrument, the culture media segment held largest revenue share of 40.7% in 2023.
• By instrument, disposable devices segment is anticipated to reach at the fastest CAGR during forecast period.
• By procedure type, fresh non-donor segment dominated the market with largest revenue share of 42.40% in 2024.
• By providers, the fertility clinics segment has leading the market in 2024 and is projected to witness fastest growth over the forecast period.
• By providers, the hospitals segment is projected to witness a substantial CAGR over the forecast period.

In Vitro Fertilization Market Growth Factors

• Increasing Use of Noninvasive Prenatal Testing: A noninvasive prenatal test (NIPT) involves a blood test and is an accurate screening test. This test can help detect chromosomal abnormalities in developing babies. This blood test is done in the first trimester of pregnancy. The advanced procedure of non-invasive blood testing ensures that the baby is healthy and developing normally. NIPT is a safe procedure and a very effective method of screening for conditions such as Down syndrome, Patau syndrome, Turner syndrome, and Edward syndrome.
• Increasing Need to Overcome Infertility in Men and Women: In addition to the natural aging process of a woman's eggs, infertility can be related to ovulation problems, blockages in the reproductive organs, low sperm count, and scarring or damage to the fallopian tubes. IVF involves retrieving eggs and sperm or using donated eggs and sperm, which eliminates the need for a healthy uterus.
• Lower Risk of Genetic Disorders: In vitro fertilization offers couples the opportunity to reduce the risk of genetic disorders in their children. Preimplantation genetic testing allows embryos to be screened for genetic abnormalities before they are transferred to the woman's uterus. By selecting embryos that are free of genetic disorders, couples can significantly reduce the risk of passing these conditions on to their children. The ability to reduce the risk of genetic disorders is a major benefit of IVF, as it allows couples to have greater peace of mind when planning their future family.

In Vitro Fertilization Market Trends

• Integrating AI in IVF: The IVF procedure is incorporating artificial intelligence (AI) more and more. For predicting pregnancy outcomes and selecting the best embryos to transfer AI is being used because it can appropriately analyze large amounts of data and identify patterns. AI can help with ongoing predictions from fertilization to the blastocyst stage by integrating with time-lapse imaging (TLI) technologies.
• Using Stem Cell Treatments: In recent years, stem cells have become a trend in IVF, with researchers studying their potential to improve fertility and pregnancy outcomes. Any cell in the body can originate from undifferentiated stem cells. They are a promising alternative for treating numerous ailments because of their capacity to regenerate new cells and heal damaged tissue. In several medical and reproductive domains, stem cell therapy is one of the most extensively studied subjects.
• Increasing Focus on Preimplantation Genetic Diagnosis: Preimplantation genetic diagnosis (PGD) is a major development in IVF that analyzes embryos for genetic abnormalities before uterine implantation. This development can lower the risk of miscarriage and further increase the likelihood of a successful pregnancy. PGD and PGD are also used to screen for genetic disorders, enabling patients who are carriers of certain diseases to have healthy children.
• Increasing Use of Robotic Technology and Nanobots: Intracytoplasmic sperm injection (ICSI) has become more automated due to recent advancements in robotics and nanotechnology. Nanotechnology has enabled the selection of suitable sperm, resulting in the development of a healthy embryo. These technologies enable real-time analysis of egg penetration, allowing doctors to select the best sperm or embryo for a given situation.

Report Scope

In Vitro Fertilization Market Dynamics

Drivers

Greater Flexibility in Family Planning

• The advantages of IVF allow couples to plan their families more freely. By preserving embryos or eggs, a couple can delay conception and have more control over when to have children. This flexibility would be especially helpful for patients undergoing medical treatments that may affect fertility, such as chemotherapy or radiation therapy. Owing to the flexibility offered by IVF, it is a popular choice for couples wanting control over family planning.

Increasing Pregnancy Success Rate

• IVF has been shown to increase the success rates of pregnancies, especially for infertile couples. IVF success rates can be influenced by several factors, including the woman's age, the quality of the sperm and eggs, and the sophistication of the fertility clinic. However, success rates have increased because of the improvements in IVF technology and procedures.

Restraints

High Costs Associated with IVF Procedures

• The cost of IVF treatment comprises of travel, prescription medication, testing, and other related costs, all of which can be expensive. Therefore the IVF procedure cannot be afforded by many couples. For some, these costs are the reason IVF is postponed or not attempted at all, especially for those without adequate financial resources or insurance coverage.

Risk of Multiple Pregnancies

• IVF treatment carries a significant possibility of multiple pregnancies. For this same reason, the technique is frequently carried out with a single embryo, even if this might be the case in some research. The main objective of most fertility clinic therapies is to achieve a single pregnancy at a time. The risks to the mother's and the babies' health rise when several fetuses grow.

Opportunities

Recent Advancements and Innovative Techniques

• Significant advancements in IVF technologies have been developed over time, opening the door to reduced dangers and increased success rates. In vitro maturation (IVM), time-lapse imaging, mitochondrial replacement treatment (MRI), and preimplantation genetic diagnosis (PGT) are a few of the methods. A greater number of patients now have hope thanks to these more recent IVF techniques, which also raise the success rates of assisted reproductive operations generally. Furthermore, the technique is being improved by these developments, becoming safer, more effective, and more widely available than before.

Rising Healthcare Expenditure and Disposable Income

• Growing disposable incomes and rising healthcare costs are making IVF treatments more affordable for more people and couples. Patients are eager to spend money on IVF despite the high expense because they want to become parents, which is fueling the market's growth.

Challenges

Risk of an Unsuccessful Cycle

• Not every IVF cycle is successful and there is no guarantee of how many cycles a person will need before pregnancy occurs. With the help of modern science, a fertility specialist can determine the chances of success depending on the individual situation.

Various Health Issues

• During the early years of IVF, the procedures and medications are blamed for birth defects, high-risk pregnancies, egg retrieval complications, and even cancer diagnoses. Recent studies refute these claims. Aside from the risk of health complications, IVF can have a detrimental effect on a person's mental state, especially in cases where IVF cycles are unsuccessful.

In Vitro Fertilization Market Segmental Analysis

The in vitro fertilization market is segmented into type, instrument, procedure, end user, and region. Based on type, the market is classified into conventional IVF, IVF with ICSI, IVF with donor eggs, mini in vitro fertilization and others. Based on instrument, the market is classified into disposable devices, culture media and equipment. Based on procedure, the market is classified into fresh donor, fresh non-donor, frozen donor, frozen non-donor. Based on end user, the market is classified into hospitals and surgical centres, fertility clinics & IVF centres, research institute and cryobanks. Based on region, the market is classified into North America, Europe, Asia-Pacific, and LAMEA.

Type Analysis

Conventional IVF: The success rate of conventional IVF is generally higher than that of other IVF techniques. The reason for this is that conventional IVF improves the probability of fertilization and embryo development by stimulating the ovaries to produce multiple eggs. Conventional IVF is a flexible option that can be used to treat a range of fertility issues, such as male and female infertility, tubal blockages, and unexplained infertility. Conventional IVF is a well-established and extensively studied procedure with decades of clinical experience, making it a trusted and reliable option for many fertility specialists and patients. These factors contribute to the growth of the segment.

IVF with ICSI: ICSI is a special form of in vitro fertilization (IVF) that is mainly used to treat severe cases of male infertility. IVF with ICSI uses special micromanipulation tools and equipment, as well as inverted microscopes, which allow embryologists to select and pick up individual sperm in a specially designed ICSI needle. Although the ICSI procedure has a success rate, it also carries some risks. An egg fertilized in this way may not develop into a viable embryo. Success rates of IVF with ICSI vary depending on the specifics of the individual case, the ICSI technique used, the skills of the person performing the procedure, the overall quality of the laboratory, the quality of the eggs, and the embryo transfer skills of the doctor specializing in infertility. Approximately 60% of IVF procedures today are performed using the ICSI technique, with success rates ranging from about 50% to 80%.

IVF with Donor Eggs: IVF using donated eggs is a fertility treatment option when a woman utilizes another woman's donated eggs. This technique is very helpful for people or couples who are having issues with the quality of their eggs, have a diminished ovarian reserve, or have genetic disorders that they do not wish to pass on to their offspring. When comparing IVF using donor eggs to IVF using the patient's eggs, the overall odds of achieving a clinical pregnancy are between 50 and 75 percent. It is 41% for those between the ages of 18 and 34 and 6% for those between the ages of 43 and 50.

Procedure Analysis

Fresh Donors: The use of fresh donor eggs allows the eggs to be fertilized while they are still fresh. In this case, the egg donor can be selected from the patient's infertility program or an egg donation agency. A 2020 study analyzed 36,925 IVF cycles and found that fresh eggs have a better success rate of 47.7% live births.

Fresh Non-Donors: High success rate, higher birth rates as compared to frozen embryos, easy implantation, and fresh embryo transfer lead to better outcomes. The higher adoption of fresh non-donor cycles coupled with the rising infertility rates across the globe is the major driver of this segment. The increasing popularity of this cycle is expected to maintain its dominance throughout the forecast period.

In Vitro Fertilization Market Revenue Share, By Procedure, 2024 (%)

Frozen Donors: With the advancements in egg freezing, the use of frozen donor eggs has become a popular alternative to fresh eggs. Like fresh egg donors, frozen egg donors are screened stimulated, and monitored in an IVF program. Their eggs are retrieved and immediately frozen. Frozen eggs are sold in batches of 6 or 10, but that is likely not the number of eggs that will be used at the end of the treatment. Frozen eggs must survive the thawing process, and unfortunately, not all of them do. Frozen eggs are more economical in terms of time.

Frozen Non-Donor: Certain factors that contribute to a high percentage are the cost-effectiveness compared to fresh non-donor and the less invasive nature of the procedure. The frozen non-donor cycle is more convenient for both patients and endocrinologists. Additionally, this cycle places less strain on the physical and mental health of women, which further drives the growth of this segment in the coming years.

End User Analysis

Fertility Clinics: Fertility clinics segment has dominated the market with highest revenue share in 2024. Fertility clinics are the first choice for couples when it comes to diagnosing fertility issues. Fertility clinics are specialized clinics that provide special care services related to pregnancy and fertility issues to couples and individuals. The increasing number of fertility clinics, increasing awareness about fertility clinics, and declining fertility rates are the major factors that have promoted the growth of the fertility clinic segment globally.

Hospitals: The hospitals segment is anticipated to experience a substantial CAGR throughout the forecast period. Widespread proliferation of hospitals, development of healthcare infrastructure in developing countries, 24/7 presence of healthcare professionals and availability of modern surgical instruments and equipment in hospitals are the major factors driving the demand for hospital services.

In Vitro Fertilization Market Regional Analysis

Why is Asia-Pacific holding the largest share in the in vitro fertilization market?

The Asia-Pacific in vitro fertilization market size was accounted for USD 9.50 billion in 2024 and is predicted to surpass around USD 16.59 billion by 2034. The market in Asia Pacific is expected to grow due to increasing awareness of infertility and the rise in medical tourism in this region. The presence of a broad population base and the promotion of medical administration are catalysts that are driving the growth of the in vitro fertilization market in China. In addition, the region is witnessing an increase in the number of registered fertility clinics, which is expected to lead to greater adoption of IVF treatments during the forecast period. For example, according to the Fertility Society of Australia, there were around 120 registered clinics in Australia in 2018, of which almost 98.0% offered IVF services. Cultural factors such as societal pressure to conceive and humiliation associated with infertility drive couples to seek IVF treatments in Japan. The technological innovations and high standard of medical infrastructure reinforce Japan's position as a frontrunner in the in vitro fertilization market in the Asia Pacific region.

What factors are driving the expected growth for in vitro fertilization market in North America?

The North America in vitro fertilization market size was valued at USD 5.19 billion in 2024 and is expected to reach around USD 9.06 billion by 2034. North America is also expected to witness an increase in demand for fertility treatments in the coming years. Lifestyle changes including inadequate nutrition, stress, increasing obesity, improper eating habits, increasing pollution, lack of exercise, and the prevalence of diseases such as diabetes have led to a higher incidence of infertility in the region. The in vitro fertilization market in Canada is characterized by an increased focus on completeness and accessibility, attempting to redress the imbalance in options for fertility therapies. The geographical differences in medical administration and ease of use are impediments to the in vitro fertilization distribution chain in Canada. The growth can be attributed to several factors such as standardization of procedures through regulatory reforms, automation, government promotion of egg/sperm storage, and introduction of more IVF treatments by industry players.

What are the growth factors of Europe in vitro fertilization market?

The Europe in vitro fertilization market size was estimated at USD 7.72 billion in 2024 and is projected to hit around USD 13.48 billion by 2034. There is a noticeable increase in medical tourism in Europe, with more Americans choosing to travel to the Czech Republic to receive lower-cost IVF treatments. Additionally, individuals who cannot afford to travel abroad are now seeking IVF treatments in the United States at about a third of the cost charged by clinics in the country. In July 2022, Fairtility received approval from the European Union to use AI for embryo evaluation. The new EU regulatory standards for medical devices have enabled the development of a commercially available AI tool that has the potential to increase the success rate of IVF procedures.

What are the driving factors of LAMEA in vitro fertilization market?

The LAMEA in IVF market was valued at USD 2.66 billion in 2024 and is expected to reach around USD 4.64 billion by 2034. The developing healthcare infrastructure, which subsequently boosts medical tourism in these regions for infertility treatment, is driving market growth in the LAMEA region. In Latin America, individual services participate voluntarily and report cycles start until termination, delivery, or miscarriage. Infertility is a universal problem with the highest prevalence in low-resource countries, particularly in sub-Saharan Africa, where infection-related fallopian tube damage is the most common cause. It is estimated that more than 180 million couples in developing countries suffer from primary or secondary infertility. In most African countries, the social stigma of childlessness still leads to isolation and abandonment. Infertility is a global problem with the highest prevalence in poor countries, particularly in sub-Saharan Africa, where infection-related fallopian tube damage is the most common cause. It is estimated that more than 180 million couples in developing countries suffer from primary or secondary infertility. In most African countries, the social stigma of childlessness still leads to isolation and neglect.

In Vitro Fertilization Market Top Companies

• Boston IVF
• Monash IVF
• Cook Medical
• TFP Thames Valley Fertility
• Pelargos IVF
• Ovation Fertility
• Irvine Scientific
• RSMC
• INVO Bioscience
• U.S. Fertility
• Nova IVF
• RMA Network (Reproductive Medicine Associates)
• Cooper Surgical Fertility
• Oxford Gene Technology
• Fortis Healthcare
• Thermo Fisher Scientific
• Genea Limited
• Shady Grove Fertility
• Group Ambroise Paré Clinic
• Bangkok IVF Center
• Bloom IVF Centre

Monash IVF, Boston IVF, and Pelargos IVF are some of the leading market players in the in vitro fertilization industry. The main factor contributing to these companies' success in the international market is the comprehensive care that their highly skilled physicians and nurses provide along with IVF and ICSI treatments. In June 2023, Progyny, Inc. and Quantum Health, Inc. combined their efforts to launch Quantum Health's Comprehensive Care treatment platform for family formation and reproductive treatments. In May 2023, WuXiAppTec expanded its toxicology testing capabilities with in vitro procedures. This expansion includes new tests as well as a new service for customized IVAs. On the other hand, companies like Bloom IVF Centre and Bangkok IVF Center focus on offering IVF treatments at a comparatively low price, which subsequently boosts medical tourism in their clinics. Other treatment providers in the IVF market include Ovation Fertility, CMRE, Shady Grove Fertility, and Group Ambroise Paré Clinic.

CEO Statements

Christy Prada, CEO of Future Fertility

• "There is a tremendous appetite for innovation and new technology – this just needs to be balanced with usability and clinical applicability."

Dr. Kshitiz Murdia, CEO & Co-Founder of Indira IVF

• "Research indicates that 40% of infertility cases are linked to male factors, another 40% to female factors, and the rest 20% can be attributed to issues in both sexes. In contrast to women who possess a keen awareness of their fertility health, a significant portion of men lack sufficient knowledge about their own reproductive health."

Recent Developments

Key players in the IVF market are pivotal in delivering a variety of innovative construction solutions, such as prefabrication techniques, sustainable materials, and advanced digital technologies. Some notable developments in the IVF market include:

• In May 2024, Vitrolife AB signed an agreement to acquire 100% of the shares in eFertility, representing a strategic move to improve standardization and digitalization in IVF clinics worldwide as part of the Vitrolife Group's broader strategy.
• In March 2024, Esco Vietnam participated in the Clinical Embryology Conference (C.E.C), highlighting the importance of collaborative forums in reproductive medicine that promote growth and innovation by sharing advances and experiences in assisted reproductive technology (ART) and in vitro fertilization (IVF) research.

These advancements mark a notable expansion in the IVF market, driven by strategic acquisitions and innovative projects. The focus is boosting sustainability, enhancing construction efficiency, and broadening product offerings to meet diverse building needs.

Market Segmentation

By Type

• Conventional IVF
• IVF with ICSI
• IVF with Donor Eggs
• Mini in vitro fertilization
• Others

By Instrument

• Disposable Devices
• Culture Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other

By Procedure

• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

By End User

• Hospitals and Surgical Centres
• Fertility Clinics & IVF Centres
• Research Institute
• Cryobanks

By Region

• North America
• Europe
• APAC
• LAMEA